ID   LRRF1_RAT               Reviewed;         738 AA.
AC   Q66HF9;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   29-MAY-2024, entry version 121.
DE   RecName: Full=Leucine-rich repeat flightless-interacting protein 1;
DE            Short=LRR FLII-interacting protein 1;
GN   Name=Lrrfip1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Brown Norway; TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=10364563; DOI=10.1161/01.res.84.11.1258;
RA   Khachigian L.M., Santiago F.S., Rafty L.A., Chan O.L.-W., Delbridge G.J.,
RA   Bobik A., Collins T., Johnson A.C.;
RT   "GC factor 2 represses platelet-derived growth factor A-chain gene
RT   transcription and is itself induced by arterial injury.";
RL   Circ. Res. 84:1258-1267(1999).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302; SER-560 AND SER-675, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional repressor which preferentially binds to the
CC       GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate
CC       expression of TNF, EGFR and PDGFA. May control smooth muscle cells
CC       proliferation following artery injury through PDGFA repression. May
CC       also bind double-stranded RNA. Positively regulates Toll-like receptor
CC       (TLR) signaling in response to agonist probably by competing with the
CC       negative FLII regulator for MYD88-binding (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:10364563}.
CC   -!- SUBUNIT: Homodimer. May also form higher oligomers. Interacts with FLII
CC       (By similarity). Interacts with MYD88 (By similarity). Competes with
CC       FLII for MyD88-binding, even in the absence of LPS (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}.
CC   -!- INDUCTION: Up-regulated after artery wall injury (at protein level).
CC       {ECO:0000269|PubMed:10364563}.
CC   -!- DOMAIN: The DNA-binding domain is intrinsically unstructured.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The coiled coil mediates dimerization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the LRRFIP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC081883; AAH81883.1; -; mRNA.
DR   RefSeq; NP_001014291.1; NM_001014269.1.
DR   AlphaFoldDB; Q66HF9; -.
DR   SMR; Q66HF9; -.
DR   BioGRID; 266442; 1.
DR   STRING; 10116.ENSRNOP00000045021; -.
DR   iPTMnet; Q66HF9; -.
DR   PhosphoSitePlus; Q66HF9; -.
DR   jPOST; Q66HF9; -.
DR   PaxDb; 10116-ENSRNOP00000045021; -.
DR   GeneID; 367314; -.
DR   KEGG; rno:367314; -.
DR   UCSC; RGD:1359548; rat.
DR   AGR; RGD:1359548; -.
DR   CTD; 9208; -.
DR   RGD; 1359548; Lrrfip1.
DR   VEuPathDB; HostDB:ENSRNOG00000019892; -.
DR   eggNOG; KOG2010; Eukaryota.
DR   HOGENOM; CLU_018924_0_0_1; -.
DR   InParanoid; Q66HF9; -.
DR   OrthoDB; 5363471at2759; -.
DR   PhylomeDB; Q66HF9; -.
DR   TreeFam; TF314109; -.
DR   PRO; PR:Q66HF9; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000019892; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 1.20.5.4090; -; 1.
DR   InterPro; IPR019139; LRRFIP1/2.
DR   PANTHER; PTHR19212; LEUCINE RICH REPEAT IN FLII INTERACTING PROTEIN; 1.
DR   PANTHER; PTHR19212:SF5; LEUCINE-RICH REPEAT FLIGHTLESS-INTERACTING PROTEIN 1; 1.
DR   Pfam; PF09738; LRRFIP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Coiled coil; Cytoplasm; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   CHAIN           2..738
FT                   /note="Leucine-rich repeat flightless-interacting protein
FT                   1"
FT                   /id="PRO_0000248394"
FT   REGION          40..98
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          253..738
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          479..580
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250"
FT   COILED          94..194
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        40..64
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        68..98
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        253..275
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        281..295
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        313..332
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        366..380
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        381..395
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        440..465
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        515..537
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        538..563
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        577..592
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        603..639
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        723..738
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   MOD_RES         83
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   MOD_RES         84
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   MOD_RES         88
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   MOD_RES         92
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UZ39"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UZ39"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UZ39"
FT   MOD_RES         551
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   MOD_RES         560
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         675
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         701
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
FT   CROSSLNK        249
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q32MZ4"
SQ   SEQUENCE   738 AA;  80019 MW;  10D6F003160948B7 CRC64;
     MTSPEGAQNK EIDCLSPEAQ RLAEARLAAK RAARAEAREI RMKELERQQK EVEERPDKDF
     AEKGSRNMPS LSAATLASLG GTSSRRGSGD TSISMDTEAS IREIKDSLAE VEEKYKKAMV
     SNAQLDNEKT NFMYQVDTLK DMLLELEEQL AESQRQYEEK NKEFEREKHA HSILQFQFAE
     VKEALRQREE MLEKHGIILN SEIATNGETS DTVNDVGYQA PTKITKEELN ALKAAGEGTL
     GKAKEVEVKK EIVEKVGQRE TLQDSEQEQP KLNTGKDCVD RGVLHPGEKA ENQRPVEDSA
     LSPGPLAGAK CEQEVQSQDQ ENTSILKSPE QIESHEVTNK SDSRDSNSPE PSSCRGGLDS
     EVSGPTALGI KNQSENSMDS QGKENQEDLG KGSFEPRPDH VLGQTPEIDK VSCTDSRGTG
     GNHLEDVVQA GDTIVEDQVG TMASAEQSKS MENHIGRSLN DGLGQSSERE LAHEAAELEE
     ALTQSSQAGG ENTVTEAEDA AVRDEKPLQA DVQATPAAPT VQSGHQDTTG PGSTDTKHTS
     PHAKERNKAK SEQQAEALDS PQKKTKNKKK KNKKKKAAAP METCKDANEE SSCQDPDVGD
     GEEEERVQAT DKKWAAETPE LKEDPQSRPS GKQNDAEEDS GPAEGPTDVL DQNSLQCADG
     DISPVGRKGP QRDASQIGGE EGLVPSQHPG QADEKGIEGH SVDNSDLSGE LGGFNSESGE
     QAREEVGNSK SKEDCTMS
//
